{
    "nctId": "NCT01724242",
    "briefTitle": "Vaginal DHEA for Women After Breast Cancer",
    "officialTitle": "Vaginal DHEA to Ease Vaginal Dryness in Women With a Contraindication to Estrogen Therapy",
    "overallStatus": "WITHDRAWN",
    "conditions": "Vaginal Dryness, Breast Cancer, Urinary Incontinence, Quality of Life, Sexual Satisfaction",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "improvement in vaginal dryness",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women post menopausal aged 35-55, suffering from vaginal dryness, secondary to chemotherapy for breast cancer, within 5 years of diagnosis. Follicle Stimulating Hormone and Estradiol levels in the post menopausal range are needed.\n\nExclusion Criteria:\n\n* women using products to alleviate vaginal dryness.\n* women taking medication for urinary incontinence\n* women not sexually active, for other reasons.",
    "sex": "FEMALE",
    "minimumAge": "35 Years",
    "stdAges": "ADULT"
}